XCel Brands, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that XCel Brands, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $31.71M | Mar 30, 2018 |
| FY2017 | Dec 31, 2016 | $32.69M | Mar 30, 2018 |
| FY2016 | Dec 31, 2015 | $27.72M | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | $20.71M | Mar 17, 2016 |
| FY2014 | Dec 31, 2013 | $13.17M | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $12.70M | Apr 11, 2014 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.94M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $7.81M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $10.84M | May 28, 2025 |
| FY2023 | Dec 31, 2022 | $17.80M | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | $27.27M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $23.99M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $31.46M | Apr 23, 2021 |
| FY2019 | Dec 31, 2018 | $32.76M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $31.71M | Apr 1, 2019 |
| FY2016 | Dec 31, 2016 | $32.56M | Mar 24, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($17.46M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($22.40M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($21.05M) | May 28, 2025 |
| FY2023 | Dec 31, 2022 | ($4.02M) | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | ($12.18M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($12.94M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($3.43M) | Apr 23, 2021 |
| FY2019 | Dec 31, 2018 | $1.09M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | ($10.12M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $2.74M | Mar 30, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($13.23M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($21.41M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($20.64M) | May 28, 2025 |
| FY2023 | Dec 31, 2022 | ($2.26M) | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | ($12.56M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($16.41M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($2.61M) | Apr 23, 2021 |
| FY2019 | Dec 31, 2018 | $3.93M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | ($9.22M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $4.87M | Mar 30, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.65M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $6.84M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $13.26M | May 28, 2025 |
| FY2023 | Dec 31, 2022 | $16.28M | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | $14.36M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $9.74M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $5.55M | Apr 23, 2021 |
| FY2019 | Dec 31, 2018 | $5.21M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $4.70M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $5.69M | Mar 30, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($7.02M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($4.72M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($6.55M) | May 28, 2025 |
| FY2023 | Dec 31, 2022 | ($14.18M) | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | ($6.56M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $3.19M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $3.50M | Apr 23, 2021 |
| FY2019 | Dec 31, 2018 | $6.59M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $4.68M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $7.92M | Mar 30, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.0K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $112.0K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $100.0K | May 28, 2025 |
| FY2023 | Dec 31, 2022 | $265.0K | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | $1.10M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $748.0K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $1.13M | Apr 23, 2021 |
| FY2019 | Dec 31, 2018 | $1.48M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $208.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $2.16M | Mar 30, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.95M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $53.76M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $71.66M | May 28, 2025 |
| FY2023 | Dec 31, 2022 | $88.94M | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | $125.78M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $123.05M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $143.19M | Apr 23, 2021 |
| FY2019 | Dec 31, 2018 | $138.06M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $135.02M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $151.12M | Mar 30, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.12M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $25.36M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $23.49M | May 28, 2025 |
| FY2023 | Dec 31, 2022 | $18.80M | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | $50.84M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $36.80M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $44.74M | Apr 23, 2021 |
| FY2019 | Dec 31, 2018 | $38.18M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $37.32M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $44.95M | Mar 30, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.96M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $30.42M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $50.03M | May 28, 2025 |
| FY2023 | Dec 31, 2022 | $70.82M | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | $74.28M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $85.75M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $98.10M | Apr 23, 2021 |
| FY2019 | Dec 31, 2018 | $99.88M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $97.69M | Apr 1, 2019 |
| FY2018 | Dec 31, 2016 | $106.17M | Apr 1, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $0 | Mar 30, 2018 |
| FY2017 | Dec 31, 2016 | $12.37M | Mar 30, 2018 |
| FY2016 | Dec 31, 2015 | $12.37M | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | $12.37M | Mar 17, 2016 |
| FY2014 | Dec 31, 2013 | $12.37M | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $12.37M | Apr 11, 2014 |
| FY2012 | Dec 31, 2011 | $12.37M | Mar 15, 2013 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($93.71M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($76.24M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($53.85M) | May 28, 2025 |
| FY2023 | Dec 31, 2022 | ($32.80M) | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | ($28.78M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($16.60M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($3.66M) | Apr 23, 2021 |
| FY2019 | Dec 31, 2018 | ($233.0K) | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | ($1.32M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $8.80M | Mar 30, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.15M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $1.25M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $3.00M | May 28, 2025 |
| FY2023 | Dec 31, 2022 | $4.61M | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | $4.48M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $4.96M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $4.64M | Apr 23, 2021 |
| FY2019 | Dec 31, 2018 | $8.84M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $10.19M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $14.13M | Mar 30, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.71M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $6.57M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $4.72M | May 28, 2025 |
| FY2022 | Dec 31, 2021 | $28.03M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $16.64M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $18.82M | Apr 23, 2021 |
| FY2018 | Dec 31, 2018 | $19.58M | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | $24.95M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $31.92M | Mar 30, 2018 |
| FY2016 | Dec 31, 2015 | $41.03M | Mar 24, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (5) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | (9) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | (10) | May 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Apr 23, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 1, 2019 |
| FY2013 | Dec 31, 2013 | 0 | Apr 11, 2014 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (5) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | (9) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | (10) | May 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Apr 23, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 1, 2019 |
| FY2013 | Dec 31, 2013 | 0 | Apr 11, 2014 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5.88M | Apr 15, 2026 |
| FY2024 | Mar 24, 2025 | 2.38M | May 28, 2025 |
| FY2025 | Mar 12, 2025 | 2.38M | Apr 15, 2026 |
| FY2025 | Mar 11, 2025 | 23.80M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 2.37M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 1.98M | May 28, 2025 |
| FY2023 | Dec 31, 2022 | 19.62M | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | 19.57M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 19.26M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | 18.87M | Apr 23, 2021 |